| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 01/18/2012 | EP2407473A2 Method for producing phosphorus-containing compounds |
| 01/18/2012 | EP2407466A1 Piperazine compound capable of inhibiting prostaglandin d synthase |
| 01/18/2012 | EP2407453A1 PGD2 receptor antagonist |
| 01/18/2012 | EP2407176A1 Ameliorating agent for chronic obstructive pulmonary disease |
| 01/18/2012 | EP2406283A1 Antibody molecules having binding specificity for human il-13 |
| 01/18/2012 | EP2406255A1 4-oxadiazol-2 -yl- indazoles as inhibitors of p13 kinases |
| 01/18/2012 | EP2406249A1 Indole derivatives as ikk2 inhibitors |
| 01/18/2012 | EP2406235A2 Process for the preparation of bosentan |
| 01/18/2012 | EP2406227A1 Process for manufacturing 5-(2-{[6-(2,2-difluoro-2-phenylethoxy) hexyl]amino}-1- hydroxyethyl)-8-hydroxyquinolin-2(1h)-one. |
| 01/18/2012 | EP2406223A2 Bis aromatic compounds for use as ltc4 synthase inhibitors |
| 01/18/2012 | EP2406220A1 Bis aromatic compounds for use as ltc4 synthase inhibitors |
| 01/18/2012 | EP2405929A1 Treatment methods for autoimmune disorders |
| 01/18/2012 | EP2405928A1 Treatment and diagnostic methods for hypersensitive disorders |
| 01/18/2012 | EP2327413A9 Pharmaceutical composition comprising FGF18 and IL-1 antagonist and method of use |
| 01/18/2012 | EP1831202B1 Pyrrolinidium derivatives as m3 muscarinic receptors |
| 01/18/2012 | EP1826197B1 Aminocarboxylic acid derivative and medicinal use thereof |
| 01/18/2012 | EP1808446B1 Il-18 receptor antagonist and pharmaceutical composition containing the antagonist |
| 01/18/2012 | EP1713471B1 Combination of anticholinergics and inhibitors of phosphodiesterase type 4 for the treatment of respiratory diseases |
| 01/18/2012 | EP1257822B1 Her-2 binding antagonists |
| 01/18/2012 | EP1256574B1 Nitrogen-containing compounds having kinase inhibitory activity and drugs containing the same |
| 01/18/2012 | CN102325532A Inhalation of levofloxacin for reducing lung inflammation |
| 01/18/2012 | CN102325530A 5- (2-{ [6- (2, 2-difluoro-2-phenylethoxy) hexyl] amino} -1-hydroxyethyl) -8-hydroxyquinolin-2 (ih)-one for treatment of lung function |
| 01/18/2012 | CN102325528A Activated blood coagulation factor X (FXa) inhibitor |
| 01/18/2012 | CN102321626A Means for inhibiting the expression of protein kinase 3 |
| 01/18/2012 | CN102321077A Chromane substituted benzimidazoles and their use as acid pump inhibitors |
| 01/18/2012 | CN102319411A Medicament for treating nasosinusitis |
| 01/18/2012 | CN102319403A Traditional Chinese medicine preparation for treating chronic bronchitis |
| 01/18/2012 | CN102319387A Traditional Chinese medicine composition for treating chronic cough |
| 01/18/2012 | CN102319385A Medicament for treating emphysema and preparation method thereof |
| 01/18/2012 | CN102319374A Preparation method of Chinese medicinal lotion for treating cough bedsore |
| 01/18/2012 | CN102319367A Medicine used for treating chronic pharyngolaryngitis and vocal cord diseases |
| 01/18/2012 | CN102319364A Manufacturing method of dendrobium candidum wallex lindll pure powder tablets |
| 01/18/2012 | CN102319354A Heat clearing and detoxication oral liquid, and preparation method thereof |
| 01/18/2012 | CN102319349A Chinese medicinal composition for treating pneumonia and preparation method thereof |
| 01/18/2012 | CN102319348A Medicament for treating chronic pharyngitis |
| 01/18/2012 | CN102319308A Preparation method of heat-clearing cough-relieving oral liquid for children |
| 01/18/2012 | CN102319295A Medicament for treating upper respiratory tract infection |
| 01/18/2012 | CN102319294A Double-vanilla preparation and preparation method thereof |
| 01/18/2012 | CN102319292A Essential oil component for treating rhinitis and application thereof |
| 01/18/2012 | CN102319283A Preparation method for veterinary licorice root particles |
| 01/18/2012 | CN102319277A Method for preparing fumaria capreolata L. total alkaloid extract |
| 01/18/2012 | CN102319231A Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid |
| 01/18/2012 | CN102319224A Compound methoxyphenamine rapid-release slow-release osmotic pump preparation |
| 01/18/2012 | CN102319209A Nasal pharmaceutical formulations and methods of using the same |
| 01/18/2012 | CN102018857B Externally applied medicament for treating chronic rhinitis |
| 01/18/2012 | CN101978983B Chinese medicinal composition for treating acute upper respiratory infection and preparation method thereof |
| 01/18/2012 | CN101953980B Allium macrostemon and pepperweed seed mixture for treating chronic obstructive pulmonary disease (COPD) by adopting phlegm removing and turbidity resolving method |
| 01/18/2012 | CN101829260B Chinese medicine sachet for preventing and treating influenza and preparation method thereof |
| 01/18/2012 | CN101810644B Production method of ant essential oil and ant oil soft capsule |
| 01/18/2012 | CN101524493B Multifunctional Chinese medicine honeyed pill |
| 01/18/2012 | CN101502614B Medicine tea for stopping snore |
| 01/18/2012 | CN101461566B Atomized liquid of electronic smoke |
| 01/18/2012 | CN101461565B Medicinal health type tobacco juice for electronic smoke |
| 01/18/2012 | CN101304969B Benzene derivative or salt thereof |
| 01/18/2012 | CN101107226B Phenoxyacetic acid derivatives useful for treating respiratory diseases |
| 01/18/2012 | CN101049424B Medication for treating infection in respiratory system |
| 01/17/2012 | US8097649 Composition and method for stabilizing the same |
| 01/17/2012 | US8097621 Pyrazolo[4,3-d]pyrimidines as phosphodiesterase inhibitors |
| 01/17/2012 | US8097589 Using f-met-leu-x peptides to modify lymphocyte response to immunoglobulin-e challenge; inhibiting mucous release into airways of patients; immunotherapy |
| 01/17/2012 | US8097585 Methods of treating inflammation by administration of heme oxygenase-1 and products of heme degradation |
| 01/17/2012 | US8097282 aqueous dispersion comprising insoluble therapeutic or diagnostic agent particles having a surface modifier; treating a respiratory illness |
| 01/17/2012 | US8097279 Chewable soft capsule |
| 01/17/2012 | DE202011003763U1 Alkoholfreie Zusammensetzungen auf pflanzlicher Basis sowie deren Verwendung Alcohol-free compositions based on plants and their use |
| 01/17/2012 | CA2527419C Novel lipid mixtures for synthetic surfactants |
| 01/17/2012 | CA2473986C Indazole compounds useful as protein kinase inhibitors |
| 01/17/2012 | CA2451244C Purine derivatives as a2b adenosine receptor antagonists |
| 01/17/2012 | CA2385456C 9-(piperazinylalkyl) carbazoles as bax-modulators |
| 01/17/2012 | CA2375214C Surfactant protein c esters |
| 01/12/2012 | WO2012006599A2 Compstatin analogs for treatment of rhinosinusitis and nasal polyposis |
| 01/12/2012 | WO2012006500A2 Monoclonal antibodies against hepatitis c virus core protein |
| 01/12/2012 | WO2012005229A1 N-hydroxyformamide derivative and pharmaceutical containing same |
| 01/12/2012 | WO2012005227A1 Tetrahydrocarboline derivative |
| 01/12/2012 | WO2012004900A1 Thienopyrimidine compounds |
| 01/12/2012 | WO2012004330A1 Nos-inhibitor l-nil for use in chronic pulmonary diseases |
| 01/12/2012 | WO2012003810A1 Regulatory factor of foxp3 and regulatory t cells and use thereof |
| 01/12/2012 | WO2012003784A1 Pyrazine derivatives,process for manufacture and use thereof |
| 01/12/2012 | WO2011118957A3 Composition for treating inflammatory, allergic or asthma diseases, containing paprika extracts |
| 01/12/2012 | US20120010299 Non-prescription medicine, vital fluid, and/or nutritional supplement |
| 01/12/2012 | US20120010297 Curcuminoids and its metabolites for the application in allergic ocular/nasal conditions |
| 01/12/2012 | US20120010272 RNA Interference Mediated Inhibition of Apoptosis Signal-Regulating Kinase 1 (ASK1) Gene Expression Using Short Interfering Nucleic Acid (siNA) |
| 01/12/2012 | US20120010257 Modulators of cystic fibrosis transmembrane conductance regulator |
| 01/12/2012 | US20120010244 Indole derivatives as ikk2 inhibitors |
| 01/12/2012 | US20120010236 Quinuclidine compounds having quaternary ammonium group, its preparation method and use as blocking agents of acetylcholine |
| 01/12/2012 | US20120010223 Isothiazolo-pyrimidinedione derivatives as trpai modulators |
| 01/12/2012 | US20120010215 Treatment of bacterial diseases of the respiratory organs |
| 01/12/2012 | US20120010214 3-(IMIDAZOLYL)-PYRAZOLO[3,4-b]PYRIDINES |
| 01/12/2012 | US20120010213 Oral controlled release dosage forms for water soluble drugs |
| 01/12/2012 | US20120010203 Triazolopyridazines as par1 inhibitors, production thereof, and use as medicaments |
| 01/12/2012 | US20120010198 Methods for Treating Sleep Disorders by Cholecystokinin (CCK) Receptor B Antagonists |
| 01/12/2012 | US20120010191 Pyridone and aza-pyridone compounds and methods of use |
| 01/12/2012 | US20120010188 Imidazopyridine Compounds |
| 01/12/2012 | US20120010179 Methods of using a thiazole derivative |
| 01/12/2012 | US20120010162 Method for treatment of lung infections by administration of aminoglycosides by aerolisation |
| 01/12/2012 | US20120010145 Methods and Compositions for Delivery of Medicaments to the Lungs |
| 01/12/2012 | US20120010126 Recombinant surfactant protein d compositions and methods of use thereof |
| 01/12/2012 | US20120009253 Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds of the lower respiratory tract |
| 01/12/2012 | US20120009226 Highly pure laquinimod or a pharmaceutically acceptable salt thereof |
| 01/12/2012 | US20120009196 Monoclonal antibodies against hepatitis c virus core protein |
| 01/12/2012 | US20120009195 Antibody neutralizers of human granulocyte macrophage colony stimulating factor |
| 01/12/2012 | US20120009190 Identification and method for using the pre-ligand assembly domain of the il-17 receptor |